and Zynerba’s transdermal CBD gel ZYN002 in Fragile X syndrome.
Results for “Financial Instruments and Exchange Act”
Search across the indexed text of every released document.
Names that match “Financial Instruments and Exchange Act”
25,457 documents found
and a Phase II/III trial in infantile spasms. The first
and 37% for Epidiolex vs. 10% for placebo
and reached statistical significance in patients taking
many of which were other scales measuring functionality and
headache (7% CBD vs. 8.9% placebo) and somnolence
and the company is testing numerous other cannabinoids. GW’s CBDV
much work and change still needs to occur in order for this industry to
and (ii) no part of his or her compensation was
LLC and or its affiliates make a market in the stock of GW Pharmaceuticals Plc
e-mailed or made available to third-party aggregators. Cowen and Company
objectives or needs and are not intended as recommendations of investment strategy. The recipients of this report must make their own
LLC in order to prevent and avoid conflicts of
investors must regard such branded reports as providing stand-alone analysis and reflecting the
User Agreement and other general information related to this report